Pyrimethamine to Treat Autoimmune Lymphoproliferative Syndrome

NCT00065390 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

8

Enrollment

NIH

Sponsor class

Conditions

Autoimmune Disease
Lymphatic Disease
Lymphoproliferative Disorder

Interventions

DRUG: Pyrimethamine

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)